Primary record
N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide; N-[4-(3-Chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]acrylamide;
- 库存
- 5,844 克
- 纯度
- 99.2 %
- CAS
- 267243-28-7
化合物标识与属性
- CAS
- 267243-28-7
- PubChem CID
- 156414
- SMILES
- C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4
- Canonical SMILES
- C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1
名称与同义词
- Canertinib
- 267243-28-7
- canertinibum
- Alumina
- Canertinib free base
- Canertinib HCl
- Canertinib (CI-1033)
- Canertinib [INN]
- CI-1033
- Canertinib dihydrochloride
- canertinibumcanertinib
- CANETINIB
- C24H25ClFN5O3
- Canertinib [INN:BAN]
- CI-1033(Canertinib)
- C78W1K5ASF
- DISCONTINUED""
- Canertinib (CI1033
- A1CEA
- CANERTINIB [MI]
- UNII-C78W1K5ASF
- RefChem:917970
- Canertinib, CI 1033
- Caneritinib; CI-1033
- PD-183805
- DTXSID8048943
- CHEMBL31965
- D0YB3W
- Canertinib - CI-1033
- CI-1033 (Canertinib)
- AC1L4G5R
- CANERTINIB [WHO-DD]
- MFCD09837878
- SCHEMBL54837
- DTXCID1028869
- cc-178
- CHEBI:61399
- MLS004774146
- PD 183805 dihydrochloride
- BDBM4779
- CHEMBL545315
- cid_156414
- GTPL5675
- orb1301044
- SCHEMBL29368458
- SCHEMBL29623482
- SCHEMBL29655741
- CTK8E6872
- KS-00000XPE
- 267243-28-7 (free base)
- AOB6938
- EX-A078
- QCR-127
- SYN1030
- Canertinib dihydrochloride (USAN)
- Canertinib dihydrochloride [USAN]
- CI1033
- OMZCMEYTWSXEPZ-UHFFFAOYSA-N
- BCPP000301
- BS181
- GLXC-05819
- HMS3244M17
- HMS3244M18
- HMS3244N17
- BCP01790
- CI 1033
- C24-H25-Cl-F-N5-O3
- Tox21_113361
- ABP000862
- AN-562
- CID156414
- EBC-13032
- NCGC00182713-01
- NSC780019
- NSC801011
- s1019
- ZINC27439698
- PD183805
- AKOS005145818
- ACN-041314
- BCP9000481
- BCP9000482
- BCP9000525
- CCG-269588
- CS-0121
- DB05424
- NSC-780019
- NSC-801011
- RL02901
- SB16594
- SDCCGSBI-0654262.P002
- CI-1033(Canertinib)/PD-183805
- NCGC00182713-02
- NCGC00182713-07
- NCGC00182713-18
- AK468685
- AS-56189
- AT-17081
- BC256329
- HY-10367
- SC-22834
- SMR003500789
- SN-26606
- N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propoxy]quinazolin-6-yl}prop-2-enamide
- AB0035841
- PD 183805
- PD0183805
- RT-011909
- 2204B
- A1845
- CAS-267243-28-7
- FT-0654215
- N-(4-(3-chloro-4-fluorophenylamino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide
- NS00071801
- PD-0183805
- Y0252
- 289499-45-2
- EC-000.2258
- J1.314.856B
- A10211
- A25038
- N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide
- Z-3276
- 32335-EP2281815A1
- 32335-EP2292615A1
- 32335-EP2301933A1
- 32335-EP2305640A2
- 32335-EP2305671A1
- 32335-EP2311827A1
- EN300-6493001
- 499C452
- N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(3-(morpholin-4-yl)propoxy)quinazolin-6-yl)prop-2-enamide
- N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide
- I06-1255
- I14-8433
- Q5032274
- BRD-K50168500-001-07-9
- Canertinib, PD-183805, CI1033, PD183805
- Z166624030
- N-[4-(3-chloro-4-fluoro-anilino)-7-(3-morpholinopropoxy)quinazolin-6-yl]prop-2-enamide
- 2-PROPENAMIDE, N-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-(3-(4-MORPHOLINYL)PROPOXY)-6-QUINAZOLINYL)-
- 4-(3-Chloro-4-fluoroanilino)-6-(acryloylamino)-7-(3-morpholinopropoxy)quinazoline
- 6-acrylamido-N-(3-chloro-4-fluorophenyl)-7-(3-morpholinopropoxy)quinazolin-4-amine
- n-(4-(3-chloro-4-fluoroanilino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide
- N-[4-(3-chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]acrylamide
- N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-(3-morpholinopropoxy)-6-quinazolinyl]propeneamide
- N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-(3-morpholinopropoxy)quinazoline-6-yl]acrylamide
- 2-Propenamide, N-(4-((3-chloro-4-fluorophenyl) amino)-7-(3-(4-morpholinyl) propoxy)-6-quinazolinyl)-, dihydrochloride
- 2-Propenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-(4-morpholinyl)propoxy)-6-quinazolinyl)-, dihydrochloride
- 2-Propenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-
- CI-1033|||N-[4-(3-Chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide
- N-(4-(3-CHLORO-4-FLUOROPHENYL)AMINO)-7-(3-MORPHOLIN-4-YL)PROPOXY)QUINAZOLIN-6-YL)PROP-2-ENAMIDE
- N-(4-(3-chloro-4-fluorophenyl)amino)-7-(3-morpholin-4-yl)propoxy)quinazolin-6-yl)prop-2-enamide dihydrochloride
- N-[4-(3-chloro-4-fluoro-phenyl-amino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide
- N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide dihydrochloride
- N-[4-(3-Chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]acrylamide dihydrochloride
- N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide
- N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide dihydrochloride
- N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide; N-[4-(3-Chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]acrylamide;
- N-{4-(3-Chloro-4-fluoroanilino)-7-[3-(morpholin-4-yl)propoxy]quinazolin-6-yl}prop-2-enamide